{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:34:25Z","timestamp":1769045665107,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.drugpo.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T21:45:49Z","timestamp":1502228749000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Retention in medication-assisted treatment programs in Ukraine\u2014Identifying factors contributing to a continuing HIV epidemic"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-4977","authenticated-orcid":false,"given":"Kostyantyn","family":"Dumchev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergii","family":"Dvoryak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Chernova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Morozova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugpo.2017.05.014_bib0005","doi-asserted-by":"crossref","first-page":"e1000423","DOI":"10.1371\/journal.pmed.1000423","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine","volume":"8","author":"Alistar","year":"2011","journal-title":"PLoS Medicine"},{"issue":"10050","key":"10.1016\/j.drugpo.2017.05.014_bib0010","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(16)30856-X","article-title":"The perfect storm: Incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia","volume":"388","author":"Altice","year":"2016","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2017.05.014_bib0015","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: Results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9738","key":"10.1016\/j.drugpo.2017.05.014_bib0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"The Lancet"},{"issue":"Suppl. 4","key":"10.1016\/j.drugpo.2017.05.014_bib0025","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/508181","article-title":"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention","volume":"43","author":"Altice","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.014_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF03405776","article-title":"Client retention in the British Columbia Methadone Program, 1996\u20131999","volume":"95","author":"Anderson","year":"2004","journal-title":"Canadian Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.014_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1360-0443.1971.tb02386.x","article-title":"Patient characteristics associated with retention in a methadone maintenance program","volume":"66","author":"Babst","year":"1971","journal-title":"British Journal of Addiction to Alcohol and Other Drugs"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2013.09.020","article-title":"Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine","volume":"134","author":"Bachireddy","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0045","unstructured":"Balakireva, O. M., Bondar, T. V., Sereda, Y. V., & Sazonova, Y. O. (2012). Behavior monitoring and HIV prevalence among injecting drug users as a component of second generation sentinel surveillance. Retrieved from http:\/\/www.aidsalliance.org.ua\/ru\/library\/our\/2012\/me\/idu_en_2011.pdf."},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy","volume":"35","author":"Bao","year":"2009","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0055","unstructured":"Berleva, G., Dumchev, K., Kasianchuk, M., Nikolko, M., Saliuk, T., Shvab, I., & Yaremenko, O. (2012). Estimation of the size of populations most-at-risk for HIV infection in Ukraine. Retrieved from http:\/\/www.aidsalliance.org.ua\/ru\/library\/our\/2013\/SE_2012_Eng.pdf."},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.014_bib0060","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/add.12243","article-title":"At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine","volume":"108","author":"Bojko","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0065","article-title":"Using nominal group technique to assess barriers to scale up of Opioid Agonist Therapy (OAT) in Ukraine: The providers\u2019 perspective","author":"Bojko","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.014_bib0070","first-page":"255","article-title":"\u201cBureaucracy & Beliefs\u201d: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine","volume":"22","author":"Bojko","year":"2015","journal-title":"Drugs (Abingdon, England)"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2016.03.003","article-title":"The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment","volume":"66","author":"Bojko","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.014_bib0080","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S2352-3018(16)30040-6","article-title":"HIV incidence among people who inject drugs (PWIDs) in Ukraine: Results from a clustered randomised trial","volume":"3","author":"Booth","year":"2016","journal-title":"The Lancet HIV"},{"issue":"24","key":"10.1016\/j.drugpo.2017.05.014_bib0085","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/jama.282.24.2313","article-title":"Informed decision making in outpatient practice: Time to get back to basics","volume":"282","author":"Braddock","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.014_bib0090","first-page":"339","article-title":"How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting","volume":"12","author":"Braddock","year":"1997","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1016\/j.drugpo.2017.05.014_bib0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drugpo.2006.12.011","article-title":"HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine-programme description and policy implications","volume":"18","author":"Bruce","year":"2007","journal-title":"International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2012.03.002","article-title":"Predictors of methadone program non-retention for opioid analgesic dependent patients","volume":"44","author":"Cox","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugpo.2013.08.004","article-title":"What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010\u20132012? A review of the six highest burden countries","volume":"25","author":"Degenhardt","year":"2014","journal-title":"International Journal on Drug Policy"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.014_bib0110","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1997.tb02854.x","article-title":"Predictors of patient retention in a newly established methadone maintenance treatment programme","volume":"92","author":"del Rio","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-6-23","article-title":"HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: A cross-sectional survey","volume":"6","author":"Dumchev","year":"2009","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2014.01.008","article-title":"Methadone maintenance for HIV positive and HIV negative patients in Kyiv: Acceptability and treatment response","volume":"137","author":"Dvoriak","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-5-23","article-title":"On drug treatment and social control: Russian narcology\u2019s great leap backwards","volume":"5","author":"Elovich","year":"2008","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/add.12303","article-title":"Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review","volume":"109","author":"Feelemyer","year":"2014","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.014_bib0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/10826084.2012.644117","article-title":"In control? Ukrainian opiate substitution treatment patients strive for a voice in their treatment","volume":"47","author":"Golovanevskaya","year":"2012","journal-title":"Substance Use and Misuse"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: A review of the literature","volume":"86","author":"Greenfield","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.014_bib0145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jsat.2012.08.016","article-title":"Predictors of outcome after short-term stabilization with buprenorphine","volume":"44","author":"Hillhouse","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.drugpo.2017.05.014_bib0150","first-page":"382","article-title":"Bayesian model averaging: A tutorial","volume":"14","author":"Hoeting","year":"1999","journal-title":"Statistical Science"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2013.05.018","article-title":"High rates of police detention among recently released HIV-infected prisoners in Ukraine: Implications for health outcomes","volume":"133","author":"Izenberg","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0160","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). (2016a). Global AIDS Update 2016. Geneva, Switzerland."},{"key":"10.1016\/j.drugpo.2017.05.014_bib0165","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). (2016b). Prevention Gap Report. Geneva, Switzerland."},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2017.05.014_bib0170","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1136\/sti.2008.031195","article-title":"The most severe HIV epidemic in Europe: Ukraine\u2019s national HIV prevalence estimates for 2007","volume":"84","author":"Kruglov","year":"2008","journal-title":"Sexually Transmitted Infections"},{"issue":"4 Suppl. 3","key":"10.1016\/j.drugpo.2017.05.014_bib0175","doi-asserted-by":"crossref","first-page":"20897","DOI":"10.7448\/IAS.19.4.20897","article-title":"Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: Implications for retention on opioid agonist therapy","volume":"19","author":"Kutsa","year":"2016","journal-title":"Journal of the International AIDS Society"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.014_bib0180","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/cid\/ciu382","article-title":"Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: A retrospective cohort study","volume":"59","author":"Lambdin","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7517-8-32","article-title":"The Soviet doctor and the treatment of drug addiction: A difficult and most ungracious task","volume":"8","author":"Latypov","year":"2011","journal-title":"Harm Reduction Journal"},{"issue":"8","key":"10.1016\/j.drugpo.2017.05.014_bib0190","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.014_bib0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial","volume":"152","author":"Lucas","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2016.06.011","article-title":"Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","volume":"165","author":"Makarenko","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2017.05.037","article-title":"Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","author":"Makarenko","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0210","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.014_bib0215","first-page":"163","article-title":"In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine","volume":"23","author":"Mazhnaya","year":"2016","journal-title":"Drugs (Abingdon, England)"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0220","series-title":"21st International AIDS Conference (AIDS 2016)","article-title":"Using mixed methods to understand HIV treatment cascade among opioid agonist therapy (OAT) patients and people who inject drugs in five Ukrainian cities","author":"Mazhnaya","year":"2017"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.014_bib0225","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up","volume":"6","author":"Metzger","year":"1993","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.014_bib0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/cid\/cit427","article-title":"Optimizing care for HIV-infected people who use drugs: Evidence-based approaches to overcoming healthcare disparities","volume":"57","author":"Meyer","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0235","unstructured":"MoH of Ukraine. (2013). HIV infection in Ukraine informational bulletin #39. Retrieved from http:\/\/ucdc.gov.ua\/pages\/diseases\/hiv_aids\/monitoring\/information-bulletins."},{"key":"10.1016\/j.drugpo.2017.05.014_bib0240","unstructured":"MoH of Ukraine. (2015). HIV infection in Ukraine informational bulletin #43. Retrieved from http:\/\/ucdc.gov.ua\/pages\/diseases\/hiv_aids\/monitoring\/information-bulletins."},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00126334-200401010-00006","article-title":"Differences in HIV disease progression by injecting drug use in HIV-infected persons in care","volume":"35","author":"Moore","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.014_bib0250","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.drugpo.2013.09.001","article-title":"Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine","volume":"24","author":"Morozova","year":"2013","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12874-015-0066-2","article-title":"Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia","volume":"15","author":"Morozova","year":"2015","journal-title":"BMC Medical Research Methodology"},{"issue":"22","key":"10.1016\/j.drugpo.2017.05.014_bib0260","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.014_bib0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: The role of methadone maintenance therapy","volume":"84","author":"Palepu","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2014.12.008","article-title":"Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV\/AIDS","volume":"148","author":"Polonsky","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"4 Suppl. 3","key":"10.1016\/j.drugpo.2017.05.014_bib0275","doi-asserted-by":"crossref","first-page":"20880","DOI":"10.7448\/IAS.19.4.20880","article-title":"Pre-incarceration police harassment, drug addiction and HIV risk behaviours among prisoners in Kyrgyzstan and Azerbaijan: Results from a nationally representative cross-sectional study","volume":"19","author":"Polonsky","year":"2016","journal-title":"Journal of the International AIDS Society"},{"issue":"12","key":"10.1016\/j.drugpo.2017.05.014_bib0280","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s10461-016-1375-0","article-title":"Attitudes toward addiction, methadone treatment, and recovery among HIV-infected Ukrainian prisoners who inject drugs: incarceration effects and exploration of mediators","volume":"20","author":"Polonsky","year":"2016","journal-title":"AIDS and Behavior"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.014_bib0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugpo.2009.10.005","article-title":"Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine","volume":"21","author":"Schaub","year":"2010","journal-title":"International Journal on Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.014_bib0290","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.addbeh.2004.09.004","article-title":"Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence","volume":"30","author":"Strike","year":"2005","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.drugpo.2017.05.014_bib0295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.drugpo.2007.03.001","article-title":"Integration and co-location of HIV\/AIDS, tuberculosis and drug treatment services","volume":"18","author":"Sylla","year":"2007","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0300","unstructured":"The State Service of Ukraine. (2014). Assessment of implementation of the National AIDS Programme for years 2009\u20132013 in Ukraine: synthesis report. Retrieved from http:\/\/www.ua.undp.org\/content\/ukraine\/en\/home\/library\/poverty\/assessment-of-implementation-of-the-national-aids-programme-for-.html."},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.014_bib0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2015","journal-title":"Journal of Addictive Diseases"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.014_bib0310","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0315","unstructured":"UNAIDS. (2009). Comprehensive external evaluation of the national AIDS response in Ukraine. Retrieved from http:\/\/www.unicef.org\/evaldatabase\/files\/Ukraine_National_AIDS.pdf."},{"key":"10.1016\/j.drugpo.2017.05.014_bib0320","unstructured":"UNAIDS. (2013). Global report: UNAIDS report on the global AIDS epidemic 2013. Retrieved from http:\/\/files.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/UNAIDS_Global_Report_2013_en.pdf."},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.014_bib0325","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","article-title":"Predictors of retention in methadone programs: A signal detection analysis","volume":"83","author":"Villafranca","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.014_bib0330","doi-asserted-by":"crossref","first-page":"e103657","DOI":"10.1371\/journal.pone.0103657","article-title":"Slowing of the HIV epidemic in Ukraine: Evidence from case reporting and key population surveys, 2005\u20132012","volume":"9","author":"Vitek","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.014_bib0335","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ADM.0b013e31829da05b","article-title":"A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi\u2019an","volume":"7","author":"Wei","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.drugpo.2017.05.014_bib0340","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"WHO","year":"2009"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.014_bib0345","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2471\/BLT.13.020213","article-title":"Opioid treatment in Ukraine risks losing momentum","volume":"91","author":"WHO","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"issue":"9738","key":"10.1016\/j.drugpo.2017.05.014_bib0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward","volume":"376","author":"Wolfe","year":"2010","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.014_bib0355","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"Wood","year":"2003","journal-title":"Canadian Medical Association Journal"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T13:55:08Z","timestamp":1602683708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":71,"alternative-id":["S0955395917301184"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.014","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention in medication-assisted treatment programs in Ukraine\u2014Identifying factors contributing to a continuing HIV epidemic","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}